Constellation Investments’s Bristol-Myers Squibb BMY Stock Holding History

Constellation Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.39M	Buy	37,469 +900	+2%	+$56.8K	0.44%	51
2015 Q4	$2.52M	Buy	36,569 +700	+2%	+$46.3K	0.47%	48
2015 Q3	$2.12M	Hold	35,869	–	–	0.44%	50
2015 Q2	$2.39M	Buy	35,869 +700	+2%	+$46.1K	0.46%	51
2015 Q1	$2.27M	Buy	35,169 +1,500	+4%	+$93.9K	0.43%	53
2014 Q4	$1.99M	Buy	33,669 +1,500	+5%	+$84.6K	0.4%	53
2014 Q3	$1.65M	Buy	32,169 +600	+2%	+$30K	0.37%	60
2014 Q2	$1.53M	Buy	31,569 +800	+3%	+$39.4K	0.35%	61
2014 Q1	$1.6M	Buy	30,769 +500	+2%	+$26.6K	0.39%	56
2013 Q4	$1.61M	Buy	30,269 +2,200	+8%	+$112K	0.41%	54
2013 Q3	$1.3M	Buy	28,069 +1,700	+6%	+$74.6K	0.4%	55
2013 Q2	$1.18M	Buy	+26,369	New	+$1.14M	0.41%	52

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Constellation Investments's BMY Position: Q1 2016 in Review

Constellation Investments increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q1 2016, buying an estimated $56.8K and bringing the position to 37,469 shares worth $2.39M. The position accounts for 0.44% of the portfolio, ranked #51.

Constellation Investments first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $2.52M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Constellation Investments held 37,469 shares of Bristol-Myers Squibb worth $2.39M as of Q1 2016.
Constellation Investments bought 900 Bristol-Myers Squibb shares in Q1 2016, an estimated $56.8K.
Bristol-Myers Squibb made up 0.44% of Constellation Investments's portfolio in Q1 2016, its #51 holding.
Constellation Investments first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
Constellation Investments's Bristol-Myers Squibb position peaked at $2.52M in Q4 2015.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Constellation Investments's 13F filing for Q1 2016, filed 28 Apr 2016.